TY - JOUR AU - Russell, P. J. AU - Khatri, A. PY - 2006 DA - 2006// TI - Novel gene-directed enzyme prodrug therapies against prostate cancer JO - Expert Opin Investig Drugs VL - 15 UR - https://doi.org/10.1517/13543784.15.8.947 DO - 10.1517/13543784.15.8.947 ID - Russell2006 ER - TY - JOUR AU - Nawa, A. AU - Tanino, T. AU - Luo, C. AU - Iwaki, M. AU - Kajiyama, H. AU - Shibata, K. AU - Yamamoto, E. AU - Ino, K. AU - Nishiyama, Y. AU - Kikkawa, F. PY - 2008 DA - 2008// TI - Gene directed enzyme prodrug therapy for ovarian cancer: could GDEPT become a promising treatment against ovarian cancer? JO - Anticancer Agents Med Chem VL - 8 UR - https://doi.org/10.2174/187152008783497000 DO - 10.2174/187152008783497000 ID - Nawa2008 ER - TY - JOUR AU - Singh, P. AU - Yam, M. AU - Russell, P. J. AU - Khatri, A. PY - 2010 DA - 2010// TI - Molecular and traditional chemotherapy: a united front against prostate cancer JO - Cancer Lett VL - 293 UR - https://doi.org/10.1016/j.canlet.2009.11.019 DO - 10.1016/j.canlet.2009.11.019 ID - Singh2010 ER - TY - JOUR AU - Vasey, P. A. PY - 2008 DA - 2008// TI - Ovarian cancer: front-line standard treatment in 2008 JO - Ann Oncol VL - 19 ID - Vasey2008 ER - TY - JOUR AU - Han, L. Y. AU - Kipps, E. AU - Kaye, S. B. PY - 2010 DA - 2010// TI - Current treatment and clinical trials in ovarian cancer JO - Expert Opin Investig Drugs VL - 19 UR - https://doi.org/10.1517/13543781003647966 DO - 10.1517/13543781003647966 ID - Han2010 ER - TY - JOUR AU - Zhang, Y. AU - Parker, W. B. AU - Sorscher, E. J. AU - Ealick, S. E. PY - 2005 DA - 2005// TI - PNP anticancer gene therapy JO - Curr Top Med Chem VL - 5 UR - https://doi.org/10.2174/156802605774463105 DO - 10.2174/156802605774463105 ID - Zhang2005 ER - TY - JOUR AU - Parker, W. B. AU - Allan, P. W. AU - Shaddix, S. C. AU - Rose, L. M. AU - Speegle, H. F. AU - Gillespie, G. Y. AU - Bennett, L. L. PY - 1998 DA - 1998// TI - Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cells JO - Biochem Pharmacol VL - 55 UR - https://doi.org/10.1016/S0006-2952(98)00034-3 DO - 10.1016/S0006-2952(98)00034-3 ID - Parker1998 ER - TY - JOUR AU - Sorscher, E. J. AU - Peng, S. AU - Bebok, Z. AU - Allan, P. W. AU - Bennett, L. L. AU - Parker, W. B. PY - 1994 DA - 1994// TI - Tumor cell bystander killing in colonic carcinoma utilizing the Escherichia coli DeoD gene to generate toxic purines JO - Gene Ther VL - 1 ID - Sorscher1994 ER - TY - JOUR AU - Hughes, B. W. AU - King, S. A. AU - Allan, P. W. AU - Parker, W. B. AU - Sorscher, E. J. PY - 1998 DA - 1998// TI - Cell to cell contact is not required for bystander cell killing by Escherichia coli purine nucleoside phosphorylase JO - J Biol Chem VL - 273 UR - https://doi.org/10.1074/jbc.273.4.2322 DO - 10.1074/jbc.273.4.2322 ID - Hughes1998 ER - TY - JOUR AU - Gadi, V. K. AU - Alexander, S. D. AU - Kudlow, J. E. AU - Allan, P. AU - Parker, W. B. AU - Sorscher, E. J. PY - 2000 DA - 2000// TI - In vivo sensitization of ovarian tumors to chemotherapy by expression of E. coli purine nucleoside phosphorylase in a small fraction of cells JO - Gene Ther VL - 7 UR - https://doi.org/10.1038/sj.gt.3301286 DO - 10.1038/sj.gt.3301286 ID - Gadi2000 ER - TY - JOUR AU - Martiniello-Wilks, R. AU - Wang, X. Y. AU - Voeks, D. J. AU - Dane, A. AU - Shaw, J. M. AU - Mortensen, E. AU - Both, G. W. AU - Russell, P. J. PY - 2004 DA - 2004// TI - Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudo-metastases in a mouse model of prostate cancer JO - J Gene Med VL - 6 UR - https://doi.org/10.1002/jgm.629 DO - 10.1002/jgm.629 ID - Martiniello-Wilks2004 ER - TY - JOUR AU - Hong, J. S. AU - Waud, W. R. AU - Levasseur, D. N. AU - Townes, T. M. AU - Wen, H. AU - McPherson, S. A. AU - Moore, B. A. AU - Bebok, Z. AU - Allan, P. W. AU - Secrist, J. A. PY - 2004 DA - 2004// TI - Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the escherichia coli purine nucleoside phosphorylase gene JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-04-0012 DO - 10.1158/0008-5472.CAN-04-0012 ID - Hong2004 ER - TY - JOUR AU - Lockett, L. J. AU - Molloy, P. L. AU - Russell, P. J. AU - Both, G. W. PY - 1997 DA - 1997// TI - Relative efficiency of tumor cell killing in vitro by two enzyme-prodrug systems delivered by identical adenovirus vectors JO - Clin Cancer Res VL - 3 ID - Lockett1997 ER - TY - JOUR AU - Mohr, L. AU - Shankara, S. AU - Yoon, S. K. AU - Krohne, T. U. AU - Geissler, M. AU - Roberts, B. AU - Blum, H. E. AU - Wands, J. R. PY - 2000 DA - 2000// TI - Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene JO - Hepatology VL - 31 UR - https://doi.org/10.1002/hep.510310310 DO - 10.1002/hep.510310310 ID - Mohr2000 ER - TY - JOUR AU - Bzowska, A. AU - Kulikowska, E. AU - Shugar, D. PY - 1990 DA - 1990// TI - Properties of purine nucleoside phosphorylase (PNP) of mammalian and bacterial origin JO - Z Naturforsch [C] VL - 45 ID - Bzowska1990 ER - TY - JOUR AU - du Bois, A. AU - Luck, H. J. AU - Meier, W. AU - Adams, H. P. AU - Mobus, V. AU - Costa, S. AU - Bauknecht, T. AU - Richter, B. AU - Warm, M. AU - Schroder, W. PY - 2003 DA - 2003// TI - A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer JO - J Natl Cancer Inst VL - 95 UR - https://doi.org/10.1093/jnci/djg036 DO - 10.1093/jnci/djg036 ID - du Bois2003 ER - TY - JOUR AU - Ozols, R. F. AU - Bundy, B. N. AU - Greer, B. E. AU - Fowler, J. M. AU - Clarke-Pearson, D. AU - Burger, R. A. AU - Mannel, R. S. AU - DeGeest, K. AU - Hartenbach, E. M. AU - Baergen, R. PY - 2003 DA - 2003// TI - Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.02.153 DO - 10.1200/JCO.2003.02.153 ID - Ozols2003 ER - TY - JOUR AU - Oishi, T. AU - Kigawa, J. AU - Fujiwara, K. AU - Fujiwara, M. AU - Numa, F. AU - Aotani, E. AU - Katsumata, N. AU - Kohno, I. AU - Kato, H. AU - Terakawa, N. PY - 2003 DA - 2003// TI - A feasibility study on biweekly administration of docetaxel for patients with recurrent ovarian cancer JO - Gynecol Oncol VL - 90 UR - https://doi.org/10.1016/S0090-8258(03)00322-6 DO - 10.1016/S0090-8258(03)00322-6 ID - Oishi2003 ER - TY - JOUR AU - Rose, P. G. AU - Blessing, J. A. AU - Ball, H. G. AU - Hoffman, J. AU - Warshal, D. AU - DeGeest, K. AU - Moore, D. H. PY - 2003 DA - 2003// TI - A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: a Gynecologic Oncology Group study JO - Gynecol Oncol VL - 88 UR - https://doi.org/10.1016/S0090-8258(02)00091-4 DO - 10.1016/S0090-8258(02)00091-4 ID - Rose2003 ER - TY - JOUR AU - Markman, M. PY - 2008 DA - 2008// TI - Taxanes in the management of gynecologic malignancies JO - Expert Rev Anticancer Ther VL - 8 UR - https://doi.org/10.1586/14737140.8.2.219 DO - 10.1586/14737140.8.2.219 ID - Markman2008 ER - TY - JOUR AU - Engblom, P. AU - Rantanen, V. AU - Kulmala, J. AU - Grenman, S. PY - 1999 DA - 1999// TI - Carboplatin-paclitaxel- and carboplatin-docetaxel-induced cytotoxic effect in epithelial ovarian carcinoma in vitro JO - Cancer VL - 86 UR - https://doi.org/3.0.CO;2-1 DO - 3.0.CO;2-1 ID - Engblom1999 ER - TY - JOUR AU - Vasey, P. A. AU - Jayson, G. C. AU - Gordon, A. AU - Gabra, H. AU - Coleman, R. AU - Atkinson, R. AU - Parkin, D. AU - Paul, J. AU - Hay, A. AU - Kaye, S. B. PY - 2004 DA - 2004// TI - Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma JO - J Natl Cancer Inst VL - 96 UR - https://doi.org/10.1093/jnci/djh323 DO - 10.1093/jnci/djh323 ID - Vasey2004 ER - TY - JOUR AU - Escobar, P. F. AU - Rose, P. G. PY - 2005 DA - 2005// TI - Docetaxel in ovarian cancer JO - Expert Opin Pharmacother VL - 6 UR - https://doi.org/10.1517/14656566.6.15.2719 DO - 10.1517/14656566.6.15.2719 ID - Escobar2005 ER - TY - JOUR AU - MacKenzie, S. H. AU - Clark, A. C. PY - 2008 DA - 2008// TI - Targeting cell death in tumors by activating caspases JO - Curr Cancer Drug Targets VL - 8 UR - https://doi.org/10.2174/156800908783769391 DO - 10.2174/156800908783769391 ID - MacKenzie2008 ER - TY - JOUR AU - LaCasse, E. C. AU - Mahoney, D. J. AU - Cheung, H. H. AU - Plenchette, S. AU - Baird, S. AU - Korneluk, R. G. PY - 2008 DA - 2008// TI - IAP-targeted therapies for cancer JO - Oncogene VL - 27 UR - https://doi.org/10.1038/onc.2008.302 DO - 10.1038/onc.2008.302 ID - LaCasse2008 ER - TY - JOUR AU - Voeks, D. AU - Martiniello-Wilks, R. AU - Madden, V. AU - Smith, K. AU - Bennetts, E. AU - Both, G. W. AU - Russell, P. J. PY - 2002 DA - 2002// TI - Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models JO - Gene Ther VL - 9 UR - https://doi.org/10.1038/sj.gt.3301698 DO - 10.1038/sj.gt.3301698 ID - Voeks2002 ER - TY - JOUR AU - Chou, T. C. AU - Talalay, P. PY - 1984 DA - 1984// TI - Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors JO - Adv Enzyme Regul VL - 22 UR - https://doi.org/10.1016/0065-2571(84)90007-4 DO - 10.1016/0065-2571(84)90007-4 ID - Chou1984 ER - TY - CHAP AU - Chou, T. C. AU - Hayball, M. P. PY - 1996 DA - 1996// BT - Calcusyn: Windows software for dose effect analysis PB - Anonymous Biosoft CY - Cambridge (England) ID - Chou1996 ER - TY - CHAP AU - Chou, J. AU - Chou, T. C. PY - 1988 DA - 1988// TI - Computerized simulation of dose reduction index (DRI) in synergistic drug combinations BT - Pharmacologist ID - Chou1988 ER - TY - JOUR AU - Towbin, H. AU - Staehelin, T. AU - Gordon, J. PY - 1979 DA - 1979// TI - Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications JO - Proc Natl Acad Sci USA VL - 76 UR - https://doi.org/10.1073/pnas.76.9.4350 DO - 10.1073/pnas.76.9.4350 ID - Towbin1979 ER - TY - JOUR AU - Shevchenko, A. AU - Wilm, M. AU - Vorm, O. AU - Mann, M. PY - 1996 DA - 1996// TI - Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels JO - Anal Chem VL - 68 UR - https://doi.org/10.1021/ac950914h DO - 10.1021/ac950914h ID - Shevchenko1996 ER - TY - JOUR AU - See, H. T. AU - Freedman, R. S. AU - Kudelka, A. P. AU - Burke, T. W. AU - Gershenson, D. M. AU - Tangjitgamol, S. AU - Kavanagh, J. J. PY - 2005 DA - 2005// TI - Retrospective review: re-treatment of patients with ovarian cancer with carboplatin after platinum resistance JO - Int J Gynecol Cancer VL - 15 UR - https://doi.org/10.1111/j.1525-1438.2005.15205.x DO - 10.1111/j.1525-1438.2005.15205.x ID - See2005 ER - TY - JOUR AU - Smith, J. A. AU - Ngo, H. AU - Martin, M. C. AU - Wolf, J. K. PY - 2005 DA - 2005// TI - An evaluation of cytotoxicity of the taxane and platinum agents combination treatment in a panel of human ovarian carcinoma cell lines JO - Gynecol Oncol VL - 98 UR - https://doi.org/10.1016/j.ygyno.2005.02.006 DO - 10.1016/j.ygyno.2005.02.006 ID - Smith2005 ER - TY - JOUR AU - Konstantinopoulos, P. A. AU - Fountzilas, E. AU - Pillay, K. AU - Zerbini, L. F. AU - Libermann, T. A. AU - Cannistra, S. A. AU - Spentzos, D. PY - 2008 DA - 2008// TI - Carboplatin-induced gene expression changes in vitro are prognostic of survival in epithelial ovarian cancer JO - BMC Med Genomics VL - 1 UR - https://doi.org/10.1186/1755-8794-1-59 DO - 10.1186/1755-8794-1-59 ID - Konstantinopoulos2008 ER - TY - JOUR AU - Fabbri, F. AU - Carloni, S. AU - Brigliadori, G. AU - Zoli, W. AU - Lapalombella, R. AU - Marini, M. PY - 2006 DA - 2006// TI - Sequential events of apoptosis involving docetaxel, a microtubule-interfering agent: a cytometric study JO - BMC Cell Biol VL - 7 UR - https://doi.org/10.1186/1471-2121-7-6 DO - 10.1186/1471-2121-7-6 ID - Fabbri2006 ER - TY - JOUR AU - Nguyen, H. N. AU - Sevin, B. U. AU - Averette, H. E. AU - Perras, J. AU - Ramos, R. AU - Donato, D. AU - Ochiai, K. AU - Penalver, M. PY - 1993 DA - 1993// TI - Cell cycle perturbations of platinum derivatives on two ovarian cancer cell lines JO - Cancer Invest VL - 11 UR - https://doi.org/10.3109/07357909309024851 DO - 10.3109/07357909309024851 ID - Nguyen1993 ER - TY - JOUR AU - Boehrer, S. AU - Nowak, D. AU - Hoelzer, D. AU - Mitrou, P. S. AU - Chow, K. U. PY - 2006 DA - 2006// TI - Novel agents aiming at specific molecular targets increase chemosensitivity and overcome chemoresistance in hematopoietic malignancies JO - Curr Pharm Des VL - 12 UR - https://doi.org/10.2174/138161206780574588 DO - 10.2174/138161206780574588 ID - Boehrer2006 ER - TY - JOUR AU - Eastman, A. AU - Rigas, J. R. PY - 1999 DA - 1999// TI - Modulation of apoptosis signaling pathways and cell cycle regulation JO - Semin Oncol VL - 26 ID - Eastman1999 ER - TY - JOUR AU - Oliver, F. J. AU - de la Rubia, G. AU - Rolli, V. AU - Ruiz-Ruiz, M. C. AU - de Murcia, G. AU - Murcia, J. M. PY - 1998 DA - 1998// TI - Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant JO - J Biol Chem VL - 273 UR - https://doi.org/10.1074/jbc.273.50.33533 DO - 10.1074/jbc.273.50.33533 ID - Oliver1998 ER - TY - JOUR AU - Chou, T. C. PY - 2006 DA - 2006// TI - Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies JO - Pharmacol Rev VL - 58 UR - https://doi.org/10.1124/pr.58.3.10 DO - 10.1124/pr.58.3.10 ID - Chou2006 ER - TY - JOUR AU - Kaye, S. B. AU - Vasey, P. A. PY - 2002 DA - 2002// TI - Docetaxel in ovarian cancer: phase III perspectives and future development JO - Semin Oncol VL - 29 UR - https://doi.org/10.1053/sonc.2002.34261 DO - 10.1053/sonc.2002.34261 ID - Kaye2002 ER - TY - JOUR AU - Markman, M. PY - 2003 DA - 2003// TI - Managing taxane toxicities JO - Support Care Cancer VL - 11 ID - Markman2003 ER - TY - JOUR AU - Wahl, A. F. AU - Donaldson, K. L. AU - Fairchild, C. AU - Lee, F. Y. AU - Foster, S. A. AU - Demers, G. W. AU - Galloway, D. A. PY - 1996 DA - 1996// TI - Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis JO - Nat Med VL - 2 UR - https://doi.org/10.1038/nm0196-72 DO - 10.1038/nm0196-72 ID - Wahl1996 ER - TY - JOUR AU - Li, Y. AU - Okegawa, T. AU - Lombardi, D. P. AU - Frenkel, E. P. AU - Hsieh, J. T. PY - 2002 DA - 2002// TI - Enhanced transgene expression in androgen independent prostate cancer gene therapy by taxane chemotherapeutic agents JO - J Urol VL - 167 UR - https://doi.org/10.1016/S0022-5347(05)65465-1 DO - 10.1016/S0022-5347(05)65465-1 ID - Li2002 ER - TY - JOUR AU - Yoo, G. H. AU - Piechocki, M. P. AU - Oliver, J. AU - Lonardo, F. AU - Zumstein, L. AU - Lin, H. S. AU - Kim, H. AU - Shibuya, T. Y. AU - Shehadeh, N. AU - Ensley, J. F. PY - 2004 DA - 2004// TI - Enhancement of Ad-p53 therapy with docetaxel in head and neck cancer JO - Laryngoscope VL - 114 UR - https://doi.org/10.1097/01.mlg.0000147914.51239.ed DO - 10.1097/01.mlg.0000147914.51239.ed ID - Yoo2004 ER - TY - CHAP AU - Johnson, S. W. AU - Stevenson, J. P. AU - O'Dwyer, V. T. ED - DeVita, V. T. ED - Hellman, S. ED - Rosenberg, S. A. PY - 2001 DA - 2001// TI - Cisplatin and its analogues BT - Cancer: Principles and Practice of Oncology PB - Wilkins CY - Philadelphia ID - Johnson2001 ER - TY - JOUR AU - Vasey, P. A. AU - Atkinson, R. AU - Coleman, R. AU - Crawford, M. AU - Cruickshank, M. AU - Eggleton, P. AU - Fleming, D. AU - Graham, J. AU - Parkin, D. AU - Paul, J. PY - 2001 DA - 2001// TI - Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer JO - Br J Cancer VL - 84 UR - https://doi.org/10.1054/bjoc.2000.1572 DO - 10.1054/bjoc.2000.1572 ID - Vasey2001 ER - TY - JOUR AU - Chidgey, M. AU - Dawson, C. PY - 2007 DA - 2007// TI - Desmosomes: a role in cancer? JO - Br J Cancer VL - 96 UR - https://doi.org/10.1038/sj.bjc.6603808 DO - 10.1038/sj.bjc.6603808 ID - Chidgey2007 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/11/368/prepub UR - http://www.biomedcentral.com/1471-2407/11/368/prepub ID - ref49 ER -